Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Biphasic IVM in Low Prognosis Patients Classified as Poseidon Group 1A

NCT07632300 is registered in ClinicalTrials.gov with Mỹ Đức Hospital as lead sponsor.

NCT NCT07632300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Biphasic IVM in Low Prognosis Patients Classified as Poseidon Group 1A
Lead sponsor
Mỹ Đức Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 12, 2026
Completion date
March 30, 2027
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult females, healthy adult male